Wolters Kluwer Health has announced plans to launch Medi-Span Expert AI to advance medication intelligence for digital health technology developers. The company designed the solution to deliver trusted Medi-Span content in AI-ready formats. Medi-Span, created by the makers of UpToDate®, remains a leading medication decision support solution across the healthcare ecosystem.
Now, Wolters Kluwer offers select AI developers access to a new MCP server. This server connects third-party AI applications and agents with AI-ready Medi-Span content. As a result, developers can reduce integration complexity and accelerate product development timelines.
“Agentic workflows from AI-driven prescription renewals to hospital medication verification, represent the fastest-growing segment in healthcare,” said Christopher Sullivan, Vice President and General Manager, Pharmacy and Health Technology Solutions. “Medi-Span Expert AI is being designed to transcend standard content delivery for agents, serving as the foundational intelligence for our customer’s entire medication use lifecycle. From customer’s raw data to its autonomous agents, we expect this new evolution will empower health tech leaders to manage complex workflows and help improve user drug decisions by providing AI ready content via MCP to customers and optimize patient safety solutions.”
MCP Server Delivers AI-Ready Drug Intelligence
MCP leverages Medi-Span’s expert-curated, AI-ready drug database to support modern healthcare automation. Digital health companies are rapidly building agentic AI workflows to address growing clinical demand. Consequently, providers and pharmacists expect faster and more consistent medication management systems.
However, traditional drug information integration methods, such as APIs and flat files, do not fully support agentic AI workflows. Therefore, these methods can slow innovation in AI-powered healthcare solutions.
The new MCP server from Medi-Span resolves this gap. It connects validated drug content to AI workflows in a dynamic format. Moreover, it enables AI agents to access advanced decision logic and drug dosing guardrails in real time. Developers can also reduce time to market while ensuring compliance and patient safety.
Wolters Kluwer Health plans to expand Medi-Span Expert AI across multiple clinical and administrative workflows. These applications may include clinical decision support, medication order validation, medication reconciliation, and adverse event monitoring. Additionally, the solution may support formulary management, pricing, supply chain optimization, and healthcare analytics.
“Wolters Kluwer understands both the technology and patient care side of medication. Working with Wolters Kluwer makes it possible to access evidence-based content that is backed by over 30 years of knowledge and experience, coupled with robust AI architectures,” said Jean-Claude Saghbini, Chief Technology Officer and President of Technology Services, Lumeris.
By combining medication intelligence, AI-driven workflows, and expert-curated drug databases, Wolters Kluwer aims to strengthen digital health infrastructure. The launch of Medi-Span Expert AI signals a major step toward scalable, AI-powered medication management solutions across the healthcare industry.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
